Outcomes of a 2nd comparative study had been described by Flinn et al. This is a stage III randomized Intergroup trial evaluating FC regimen vs . FAMP on your own in 278 clients acquiring their initial chemotherapy routine for B-CLL. Dosages of FC program were the same as the main https://amg-51068012.bloginwi.com/63774631/pentagalloylglucose-for-dummies